False-Positive Recall and False-Positive Biopsy Rates in Mammography Screening: A TOSYMA Trial Subanalysis
Stefanie Weigel, Hans‐Werner Hense, Veronika Weyer‐Elberich, Joachim Gerß, Walter Leonhard Heindel, for the TOSYMA Screening Trial Group, Jörg Czwoydzinski, Alexander Sommer, Thomas Decker, Susanne Wienbeck, Oliver Stephan, Karin Spieker, Sonja Baier, Andreas Renkert, Christina Barduna, Bele Dablé, Caroline Dietz, Margret Ganseforth, Axel Gräwingholt, Michael Hirning · Radiology · 2025
A subanalysis of the TOmosynthesis plus SYnthesized MAmmography (TOSYMA) trial shows that digital breast tomosynthesis plus synthesized mammography screening had lower false-positive recall rates, especially in first-round participants, and higher false-positive biopsy rates than digital mammography, which were compensated by more detected breast cancers.